These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30222608)

  • 1. Coordinating the prevention, treatment, and care continuum for HIV-associated tuberculosis in prisons: a health systems strengthening approach.
    Herce ME; Muyoyeta M; Topp SM; Henostroza G; Reid SE
    Curr Opin HIV AIDS; 2018 Nov; 13(6):492-500. PubMed ID: 30222608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imprisoned and imperiled: access to HIV and TB prevention and treatment, and denial of human rights, in Zambian prisons.
    Todrys KW; Amon JJ; Malembeka G; Clayton M
    J Int AIDS Soc; 2011 Feb; 14():8. PubMed ID: 21314929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis and HIV in people who inject drugs: evidence for action for tuberculosis, HIV, prison and harm reduction services.
    Getahun H; Gunneberg C; Sculier D; Verster A; Raviglione M
    Curr Opin HIV AIDS; 2012 Jul; 7(4):345-53. PubMed ID: 22678489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV and tuberculosis in prisons in sub-Saharan Africa.
    Telisinghe L; Charalambous S; Topp SM; Herce ME; Hoffmann CJ; Barron P; Schouten EJ; Jahn A; Zachariah R; Harries AD; Beyrer C; Amon JJ
    Lancet; 2016 Sep; 388(10050):1215-27. PubMed ID: 27427448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-associated pediatric tuberculosis: prevention, diagnosis and treatment.
    Kay A; Garcia-Prats AJ; Mandalakas AM
    Curr Opin HIV AIDS; 2018 Nov; 13(6):501-506. PubMed ID: 30286040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revision and Implementation of "Clinical Guideline for Tuberculosis and HIV in Prisons", Great Tehran Prison, Iran.
    Farhoudi B; SeyedAlinaghi S; Tabarsi P; Mohraz M; Golrokhy R; Farnia M; Shahbazi M; Alasvand R; Ebrahimi B; Esfehani J; Tashakoriyan M
    Infect Disord Drug Targets; 2018; 18(1):72-80. PubMed ID: 28521672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.
    Altice FL; Azbel L; Stone J; Brooks-Pollock E; Smyrnov P; Dvoriak S; Taxman FS; El-Bassel N; Martin NK; Booth R; Stöver H; Dolan K; Vickerman P
    Lancet; 2016 Sep; 388(10050):1228-48. PubMed ID: 27427455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to Antiretroviral Therapy and Tuberculosis Treatment in a Prison of Tehran, Iran.
    Seyed Alinaghi SA; Farhoudi B; Mohraz M; Alipour A; Golrokhy R; Hosseini M; Miri J
    Infect Disord Drug Targets; 2016; 16(3):199-203. PubMed ID: 27311561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV, prisoners, and human rights.
    Rubenstein LS; Amon JJ; McLemore M; Eba P; Dolan K; Lines R; Beyrer C
    Lancet; 2016 Sep; 388(10050):1202-14. PubMed ID: 27427457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges of TB and HIV co-treatment: updates and insights.
    Tornheim JA; Dooley KE
    Curr Opin HIV AIDS; 2018 Nov; 13(6):486-491. PubMed ID: 30080683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis screening in the federal prison system: an opportunity to treat and prevent tuberculosis in foreign-born populations.
    Saunders DL; Olive DM; Wallace SB; Lacy D; Leyba R; Kendig NE
    Public Health Rep; 2001; 116(3):210-8. PubMed ID: 12034910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of tuberculosis, HIV/AIDS, and hepatitis; in a prison of Balochistan: a cross-sectional survey.
    Wali A; Khan D; Safdar N; Shawani Z; Fatima R; Yaqoob A; Qadir A; Ahmed S; Rashid H; Ahmed B; Khan S
    BMC Public Health; 2019 Dec; 19(1):1631. PubMed ID: 31801496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis incidence and treatment completion among Ugandan prison inmates.
    Schwitters A; Kaggwa M; Omiel P; Nagadya G; Kisa N; Dalal S
    Int J Tuberc Lung Dis; 2014 Jul; 18(7):781-6. PubMed ID: 24902552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opening the Door to Zero New HIV Infections in Closed Settings.
    Torriente A; Tadion A; Hsu LN
    Health Hum Rights; 2016 Jun; 18(1):157-168. PubMed ID: 27781007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New management approaches to tuberculosis in people living with HIV.
    Mhango DV; Mzinza DT; Jambo KC; Mwandumba HC
    Curr Opin Infect Dis; 2021 Feb; 34(1):25-33. PubMed ID: 33315751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 90-90-90 HIV targets: implications for HIV-associated tuberculosis.
    Granich R; Gupta S
    Curr Opin HIV AIDS; 2018 Nov; 13(6):528-537. PubMed ID: 30188404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis treatment outcome and predictors in northern Ethiopian prisons: a five-year retrospective analysis.
    Adane K; Spigt M; Dinant GJ
    BMC Pulm Med; 2018 Feb; 18(1):37. PubMed ID: 29463234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Universal access to DOTS in Delhi Prisons: Where do we stand?
    Dhuria M; Sharma N; Chopra KK; Chandra S
    Indian J Tuberc; 2016 Jan; 63(1):39-43. PubMed ID: 27235943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent tuberculosis infection in a Malaysian prison: implications for a comprehensive integrated control program in prisons.
    Al-Darraji HA; Kamarulzaman A; Altice FL
    BMC Public Health; 2014 Jan; 14():22. PubMed ID: 24405607
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.